The Journal of Clinical Endocrinology & Metabolism · 2009 · 62 citations · 16 references
MedicineEndocrinologyPediatricsEndocrine OncologyPediatric EndocrinologyPediatric OncologyRadioiodine TherapyThyroid CancerThyroid DisordersThyroid SurgeryDiagnostic Follow-upDifferentiated Thyroid Cancer DiagnosisPediatric Thyroid DisordersRecombinant Human Thyroid-stimulating HormoneRemnant AblationRetrospective Case StudyTertiary CentersThyroid Remnant Assessment
CONTEXT: Although recombinant human TSH (rhTSH) is widely used in differentiated thyroid cancer (DTC) to aid diagnostic follow-up procedures and radioiodine thyroid remnant ablation, almost all clinical investigation was in adults. OBJECTIVE: The aim of this study was to characterize rhTSH clinical safety and peak TSH response in DTC patients 18 yr old or younger. DESIGN AND SETTING: We conducted a retrospective study involving 23 tertiary referral centers in 12 European, Asian, and Oceanian countries. PATIENTS: One hundred DTC patients (69% female, 31% male, 84% papillary, 61% N1, 18% M1) ages 4.9-18 yr at first rhTSH administration were studied. INTERVENTIONS: A total of 181 rhTSH courses were administered (range, one to eight per patient; 42% of patients received two or more courses), 92% using the approved adult regimen (one 0.9 mg im injection daily on two consecutive days), 34% including thyroid hormone withdrawal for less than 7 d ("mini-THW"). MAIN OUTCOME MEASURES: Clinical adverse event (AE) incidence, type, and severity, and peak post-rhTSH serum TSH concentrations were assessed. RESULTS: No clinical AEs occurred in 88% of rhTSH courses. Most common clinical AEs were nausea (5% of courses) and vomiting (3%). Multiple or severe AEs were rare (0.6% and 2.8% of courses, respectively); serious AEs were absent. Peak TSH concentration post-rhTSH exceeded 25 mU/liter in approximately 98% of courses. In logistic regression analyses, the rhTSH regimen, "mini-THW," peak TSH concentration, body mass index (BMI), or peak TSH concentration/unit of BMI were not associated with clinical AE occurrence. In analyses of covariance, higher BMI was associated with lower peak TSH concentrations. CONCLUSIONS: rhTSH was clinically well tolerated in pediatric DTC patients although courses preponderantly comprised the adult regimen, and repeated courses were frequent. Both the adult and reduced-dose regimens almost always sufficiently elevate TSH in children and adolescents.
16
Paul W. Ladenson, Lewis E. Braverman, Ernest L. Mazzaferri et al. · New England Journal of Medicine · 1997 · 471 citations · Full text
Medicine, Endocrinology, Radiology +17
Furio Pacini, P. W. Ladenson, Martin Schlumberger et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 448 citations
Medicine, Endocrinology, Surgery +17
Heribert Hänscheid, Markus Luster, Stephen R. Thomas et al. · PubMed · 2006 · 333 citations
Medicine, Nuclear Medicine, Surgery +17